Skip to main content

Pharmaceutical Strategies to Prevent, Treat, and Recover: Advances and Challenges in Ischemic Stroke and Hemorrhagic Stroke

141kviews
Editorial21 February 2024
Editorial: Pharmaceutical strategies to prevent, treat, and recover: advances and challenges in ischemic stroke and hemorrhagic stroke

Stroke stands as one of the primary causes of death and disability globally, particularly with an increasing incidence in developing countries (Campbell et al., 2019). At the present topic, Zhou et al. (Zhou et al., 2023) documented a fatality resulting from cerebral hemorrhage after parathyroid surgery, underscoring the existence of obscure yet highly lethal etiological factors. Complications arising from strokes are prevalent and pose significant threats to life. Zheng et al. (Zheng et al., 2023b) emphasized the need to consider lumbar cistern blockage as a potential complication following cerebral hemorrhage. However, pharmaceutical therapies for both ischemic and hemorrhagic stroke are still lacking, and the available therapeutic strategies are generally timesensitive (Jovin et al., 2022). Thus, there is an urgent need to explore the complex regulation network after stroke, which is essential for developing new generations of effective treatment strategies. Besides, translational research and clinical trials are encouraged to improve the prognosis of stroke in the future. This research topic includes 17 articles concerning pathological mechanisms, new therapeutic entities, and other attractive aspects of stroke.Concurrently, stroke research remains at the forefront of technological advancements. Qiu et al. (Qiu et al., 2022) presented a novel method for identifying differentially expressed genes in spatial transcriptomics data, exemplifying the integration of cutting-edge technologies in stroke investigations. The intricate relationship between brain function and structure is elucidated through spatial-omics techniques like spatial transcriptomics, providing researchers with a more precise characterization of biological processes with spatial data. Recognizing the pivotal role of stem cells in brain function recovery (van Velthoven et al., 2013;Bacigaluppi et al., 2016;Tornero et al., 2017), Zhang et al. (Zhang et al., 2023b) provided a comprehensive summary of the progress in stem cell applications within the realm of stroke research, offering valuable insights into their potential therapeutic utility.The pathological changes following the onset of a stroke are intricate, involving the activation/inactivation of multiple cells and pathways, extending even to the interplay between the brain and gut microbiota (Jeong et al., 2023). These complexities render stroke treatment a formidable task, and various articles on this topic have synthesized novel insights into targets and therapeutic strategies for stroke. Wang et al. reviewed approaches such as dietary intervention, fecal microbiota transplantation, probiotics, antibiotics, traditional Chinese medication, and gut-derived stem cell transplantation were explored for their influence on gut microbiota and subsequent regulation of brain recovery post-stroke (Wang et al., 2023). Yuan et al. (Yuan et al., 2022) delved into intermittent hypoxic conditions as a potential strategy for ischemic stroke prevention and treatment. Their examination encompassed current evidence, future research directions, and the proposal of intermittent hypoxia as a non-invasive, non-pharmacological, systemic, and multitargeted intervention to mitigate brain damage. Traditional Chinese medicine (TCM), often composed of multiple herbs, represents a repository of numerous chemical entities with potential efficacy in stroke treatment. Zheng et al. (Zheng et al., 2023a) conducted a comprehensive review of studies on treating stroke with Sanhua decoction, consisting of Polygonaceae, Magnoliaceae, Rutaceae, and Apiaceae, and demonstrated its multiple effects on brain repair. Similarly, Li et al. (Li et al., 2023) analyzed the potential active pharmaceutical ingredients of another TCM, Zuogui Pill, which facilitated neurite outgrowth via mTOR, p53 and Wnt signaling pathways following ischemic stroke. A pressing need persists for high-level evidence regarding herbal medicines, herbal extracts, gut microbiota, or any novel strategy for treating stroke (Zheng et al., 2023a). This need is pivotal for translating preclinical findings into clinically applicable interventions. Consequently, numerous scholars actively investigate the safety and efficacy of herbal medicines or extracts in stroke treatment through well-designed clinical trials. For instance, a multi-center, open-label, pilot randomized clinical trial conducted by Cui et al. (Cui et al., 2023) demonstrated the effectiveness of Ginkgo biloba extract in protecting patients from cognitive decline 24 weeks after acute ischemic stroke, as assessed through various evaluation methods.Additionally, specific chemical entities and therapeutic modalities have gained noteworthy attention within stroke research delineated the attributes of TJ-M2010-5, a BBB-permeable drug candidate exhibiting efficacy as a MyD88/NF-κB and ERK pathway inhibitor (Li et al., 2022). Wang et al. investigated the systemic administration of dobutamine, revealing its capacity to expedite erythrocyte clearance from the brain to cervical lymph nodes following SAH (Wang et al., 2022). Intriguingly, Pichardo-Rojas et al. conducted a comprehensive review highlighting memantine's ability to mitigate NMDA-mediated excitotoxicity, preserve intracellular ATP stores, and up-regulate neuron-specific growth factor expression, with clinical evidence proving its neuroprotective effects in ICH, ischemic stroke, and ischemic stroke-related aphasia (Pichardo-Rojas et al., 2023). Besides, anesthesias utilized during endovascular thrombectomy (EVT), including ketamine, propofol, sevoflurane, and isoflurane, have been identified as beneficial for post-stroke brain protection (Zhang et al., 2023c).Moreover, this topic includes two meta-analyses evaluating the efficacy of inclisiran and mechanical thrombectomy in stroke. Luo et al. (Luo et al., 2023) analyzed three randomized clinical trials (ORION-9, , concluding that inclisiran did not exhibit significant effects in preventing stroke in atherosclerotic cardiovascular disease patients or those at high risk. Meanwhile, Yang et al. (Yang et al., 2023) analyzed seven studies (including 1083 patients) and observed that mechanical thrombectomy with intra-arterial alteplase might enhance functional outcomes without significantly impacting recanalization. These meta-analyses contribute valuable insights to inform clinical decision-making processes.The assortment of manuscripts within this research topic underscores the diverse facets of stroke prevention, treatment, and recovery. These articles contribute novel perspectives to preclinical research and expand the horizons of clinical practice. Notably, the impact of TCM, intestinal microbiota, intermittent hypoxia, and anesthetic medications on stroke prognosis is particularly enlightening. This underscores that, while stroke remains a condition associated with high mortality and disability rates, preventive and therapeutic tools are at our disposal. This realization catalyzes advancing translational research to translate cutting-edge findings in stroke research into clinical applications expeditiously.

2,063 views

2 citations

REVIEW
13 April 2023
Sanhua decoction: Current understanding of a traditional herbal recipe for stroke
Lanlan Zheng, 2 more and Jiandao Yang

4,942 views

15 citations

ORIGINAL RESEARCH
22 June 2023
Exploring the mechanisms under Zuogui Pill’s treatment of ischemic stroke through network pharmacology and in vitro experimental verification
Li Li, 7 more and Wenlei Li

6,153 views

4 citations

CASE REPORT
11 May 2023
Postoperative cerebral hemorrhage death in a patient with secondary hyperparathyroidism: a report of one case and literature review
Peng Zhou, 5 more and Qingqing He

2,600 views

2 citations

REVIEW
28 March 2023
A retrospect and outlook on the neuroprotective effects of anesthetics in the era of endovascular therapy
Tianhao Zhang, 10 more and Xiangdong Chen

4,233 views

13 citations

ORIGINAL RESEARCH
28 February 2023
Analysis of risk factors and treatment strategies for lumbar cistern blockage after craniocerebral surgery
Min Zheng, 5 more and Qing Cai

3,830 views

2 citations

Memantine as a neuroprotective agent in ischemic stroke: Preclinical and clinical analysis
The primary mechanism for neuron death after an ischemic stroke is excitotoxic injury. Excessive depolarization leads to NMDA-mediated calcium entry to the neuron and, subsequently, cellular death. Therefore, the inhibition of the NMDA channel has been proposed as a neuroprotective measure in ischemic stroke. The high morbimortality associated with stroke warrants new therapies that can improve the functional prognosis of patients. Memantine is a noncompetitive NMDA receptor antagonist which has gained attention as a potential drug for ischemic stroke. Here we analyze the available preclinical and clinical evidence concerning the use of memantine following an ischemic stroke. Preclinical evidence shows inhibition of the excitotoxic cascade, as well as improved outcomes in terms of motor and sensory function with the use of memantine. The available clinical trials of high-dose memantine in patients poststroke have found that it can improve patients' NIHSS and Barthel index and help patients with poststroke aphasia and intracranial hemorrhage. These results suggest that memantine has a clinically relevant neuroprotective effect; however, small sample sizes and other study shortcomings limit the impact of these findings. Even so, current studies show promising results that should serve as a basis to promote future research to conclusively determine if memantine does improve the outcomes of patients’ post-ischemic stroke. We anticipate that future trials will fill current gaps in knowledge, and these latter results will broaden the therapeutic arsenal for clinicians looking to improve the prognosis of patients poststroke.

17,792 views

36 citations

ORIGINAL RESEARCH
15 December 2022
TJ-M2010-5, a novel CNS drug candidate, attenuates acute cerebral ischemia-reperfusion injury through the MyD88/NF-κB and ERK pathway
Zeyang Li, 11 more and Ping Zhou

4,890 views

16 citations

ORIGINAL RESEARCH
10 January 2023
Dobutamine promotes the clearance of erythrocytes from the brain to cervical lymph nodes after subarachnoid hemorrhage in mice
Xue Wang, 8 more and Meng-Liang Zhou

4,443 views

13 citations

Detection of differentially expressed genes in spatial transcriptomics data by spatial analysis of spatial transcriptomics: A novel method based on spatial statistics
ORIGINAL RESEARCH
29 November 2022
Detection of differentially expressed genes in spatial transcriptomics data by spatial analysis of spatial transcriptomics: A novel method based on spatial statistics
Zhihua Qiu, 4 more and Zhijian Wang
Background Spatial transcriptomics simultaneously obtains the location and amount of gene expression within a tissue section. However, current methods like FindMarkers calculated the differentially expressed genes (DEGs) based on the classical statistics, which should abolish the spatial information. Methods A new method named saSpatial was developed for both the location and the amount of gene expression. Then saSpatial was applied to detect DEGs in both inter- and intra-cross sections. DEGs detected by saSpatial were compared with those detected by FindMarkers. Results saSpatial was founded on the basis of spatial statistics. It was able to detect DEGs in different regions in the normal brain section. As for the brain with ischemic stroke, saSpatial revealed the DEGs for the ischemic core and penumbra. In addition, saSpatial characterized the genetic heterogeneity in the normal and ischemic cortex. Compared to FindMarkers, a larger number of valuable DEGs were found by saSpatial. Conclusion saSpatial was able to effectively detect DEGs in spatial transcriptomics data. It was a simple and valuable tool that could help potential researchers to find more valuable genes in the future research.

9,093 views

22 citations